Sign in

CIK 0001326110

  • Large accelerated filer

ImmunityBio, Inc.

Sign in to watch
Ticker
IBRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
431979754
Phone
+1 844-696-5235
Business address
3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
Former names
NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,119,848
in 2 filings, $1.1M under 10b5-1 plans

Net −$1,119,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cohen Cheryl −$851K Director sold 45% of stake
  2. Simon Barry J. −$269K Director sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2026-02-22 Adcock Richard CEO & President Exercise or conversion +152,439 637,904
2026-02-22 Adcock Richard CEO & President Shares withheld for taxes −77,560 $8.70 $675K 560,344
2026-02-22 Adcock Richard CEO & President Exercise or conversion · Restricted Stock Units −152,439 152,439
2026-02-10 Adcock Richard CEO & President Exercise or conversion +274,122 625,513
2026-02-10 Adcock Richard CEO & President Shares withheld for taxes −140,048 $6.93 $971K 485,465
2026-02-10 Adcock Richard CEO & President Exercise or conversion · Restricted Stock Units −274,122 548,246
2025-12-31 Adcock Richard CEO & President Exercise or conversion +34,483 368,901
2025-12-31 Adcock Richard CEO & President Shares withheld for taxes −17,510 $1.98 $35K 351,391
2025-12-31 Adcock Richard CEO & President Exercise or conversion · Restricted Stock Units −34,483 51,731
2025-02-22 Adcock Richard CEO & President Exercise or conversion +152,439 412,585
2025-02-22 Adcock Richard CEO & President Shares withheld for taxes −78,167 $3.42 $267K 334,418
2025-02-22 Adcock Richard CEO & President Exercise or conversion · Restricted Stock Units −152,439 304,878
2025-02-10 Adcock Richard CEO & President Grant or award · Restricted Stock Units +822,368 822,368
2025-02-10 Adcock Richard CEO & President Grant or award · Stock Option (right to buy) +2,812,500 2,812,500
2024-12-31 Adcock Richard CEO & President Exercise or conversion +34,483 277,621
2024-12-31 Adcock Richard CEO & President Shares withheld for taxes −17,475 $2.56 $45K 260,146
2024-12-31 Adcock Richard CEO & President Exercise or conversion · Restricted Stock Units −34,483 86,214
2024-02-22 Adcock Richard CEO & President Grant or award · Restricted Stock Units +457,317 457,317
2024-02-22 Adcock Richard CEO & President Grant or award · Stock Option (right to buy) +1,591,463 1,591,463
2024-02-05 Adcock Richard CEO & President Exercise or conversion +83,334 286,303

Page 1 of 3 · 48 trades